Global Transcatheter Structural Heart Device Market Research Report 2024
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Left Atrial Appendage Occluders
Septal Defect Occluders
Aortic Valve Replacement
Mitral Valve Repair
Mitral Valve Replacement (Experimental)
Segment by Application
Congenital Heart Defects
Aortic Stenosis
Mitral Regurgitation
Stroke
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Medtronic
Boston Scientific Corporation
Abbott
Edwards Lifesciences Corporation
Lifetech
Braile Biomedica
Micro Interventional Devices
LivaNova PLC
Cryolife
Neovasc
4C Medical Technologies
Highlife
Lepu Medical
Dinova Medtech
NewMed Medical
Venus Medtech
Hanyu Medical
Table of Content
1 Transcatheter Structural Heart Device Market Overview
1.1 Product Overview and Scope of Transcatheter Structural Heart Device
1.2 Transcatheter Structural Heart Device Segment by Type
1.2.1 Global Transcatheter Structural Heart Device Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Left Atrial Appendage Occluders
1.2.3 Septal Defect Occluders
1.2.4 Aortic Valve Replacement
1.2.5 Mitral Valve Repair
1.2.6 Mitral Valve Replacement (Experimental)
1.3 Transcatheter Structural Heart Device Segment by Application
1.3.1 Transcatheter Structural Heart Device Sales Comparison by Application: (2021-2027)
1.3.2 Congenital Heart Defects
1.3.3 Aortic Stenosis
1.3.4 Mitral Regurgitation
1.3.5 Stroke
1.3.6 Others
1.4 Global Transcatheter Structural Heart Device Market Size Estimates and Forecasts
1.4.1 Global Transcatheter Structural Heart Device Revenue 2016-2027
1.4.2 Global Transcatheter Structural Heart Device Sales 2016-2027
1.4.3 Transcatheter Structural Heart Device Market Size by Region: 2016 Versus 2021 Versus 2027
2 Transcatheter Structural Heart Device Market Competition by Manufacturers
2.1 Global Transcatheter Structural Heart Device Sales Market Share by Manufacturers (2016-2021)
2.2 Global Transcatheter Structural Heart Device Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Transcatheter Structural Heart Device Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Transcatheter Structural Heart Device Manufacturing Sites, Area Served, Product Type
2.5 Transcatheter Structural Heart Device Market Competitive Situation and Trends
2.5.1 Transcatheter Structural Heart Device Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Transcatheter Structural Heart Device Players Market Share by Revenue
2.5.3 Global Transcatheter Structural Heart Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Transcatheter Structural Heart Device Retrospective Market Scenario by Region
3.1 Global Transcatheter Structural Heart Device Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Transcatheter Structural Heart Device Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Transcatheter Structural Heart Device Market Facts & Figures by Country
3.3.1 North America Transcatheter Structural Heart Device Sales by Country
3.3.2 North America Transcatheter Structural Heart Device Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Transcatheter Structural Heart Device Market Facts & Figures by Country
3.4.1 Europe Transcatheter Structural Heart Device Sales by Country
3.4.2 Europe Transcatheter Structural Heart Device Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Transcatheter Structural Heart Device Market Facts & Figures by Region
3.5.1 Asia Pacific Transcatheter Structural Heart Device Sales by Region
3.5.2 Asia Pacific Transcatheter Structural Heart Device Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Transcatheter Structural Heart Device Market Facts & Figures by Country
3.6.1 Latin America Transcatheter Structural Heart Device Sales by Country
3.6.2 Latin America Transcatheter Structural Heart Device Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Transcatheter Structural Heart Device Market Facts & Figures by Country
3.7.1 Middle East and Africa Transcatheter Structural Heart Device Sales by Country
3.7.2 Middle East and Africa Transcatheter Structural Heart Device Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Transcatheter Structural Heart Device Historic Market Analysis by Type
4.1 Global Transcatheter Structural Heart Device Sales Market Share by Type (2016-2021)
4.2 Global Transcatheter Structural Heart Device Revenue Market Share by Type (2016-2021)
4.3 Global Transcatheter Structural Heart Device Price by Type (2016-2021)
5 Global Transcatheter Structural Heart Device Historic Market Analysis by Application
5.1 Global Transcatheter Structural Heart Device Sales Market Share by Application (2016-2021)
5.2 Global Transcatheter Structural Heart Device Revenue Market Share by Application (2016-2021)
5.3 Global Transcatheter Structural Heart Device Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Medtronic Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Boston Scientific Corporation Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Abbott Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Edwards Lifesciences Corporation
6.4.1 Edwards Lifesciences Corporation Corporation Information
6.4.2 Edwards Lifesciences Corporation Description and Business Overview
6.4.3 Edwards Lifesciences Corporation Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Edwards Lifesciences Corporation Product Portfolio
6.4.5 Edwards Lifesciences Corporation Recent Developments/Updates
6.5 Lifetech
6.5.1 Lifetech Corporation Information
6.5.2 Lifetech Description and Business Overview
6.5.3 Lifetech Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Lifetech Product Portfolio
6.5.5 Lifetech Recent Developments/Updates
6.6 Braile Biomedica
6.6.1 Braile Biomedica Corporation Information
6.6.2 Braile Biomedica Description and Business Overview
6.6.3 Braile Biomedica Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Braile Biomedica Product Portfolio
6.6.5 Braile Biomedica Recent Developments/Updates
6.7 Micro Interventional Devices
6.6.1 Micro Interventional Devices Corporation Information
6.6.2 Micro Interventional Devices Description and Business Overview
6.6.3 Micro Interventional Devices Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Micro Interventional Devices Product Portfolio
6.7.5 Micro Interventional Devices Recent Developments/Updates
6.8 LivaNova PLC
6.8.1 LivaNova PLC Corporation Information
6.8.2 LivaNova PLC Description and Business Overview
6.8.3 LivaNova PLC Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.8.4 LivaNova PLC Product Portfolio
6.8.5 LivaNova PLC Recent Developments/Updates
6.9 Cryolife
6.9.1 Cryolife Corporation Information
6.9.2 Cryolife Description and Business Overview
6.9.3 Cryolife Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Cryolife Product Portfolio
6.9.5 Cryolife Recent Developments/Updates
6.10 Neovasc
6.10.1 Neovasc Corporation Information
6.10.2 Neovasc Description and Business Overview
6.10.3 Neovasc Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Neovasc Product Portfolio
6.10.5 Neovasc Recent Developments/Updates
6.11 4C Medical Technologies
6.11.1 4C Medical Technologies Corporation Information
6.11.2 4C Medical Technologies Transcatheter Structural Heart Device Description and Business Overview
6.11.3 4C Medical Technologies Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.11.4 4C Medical Technologies Product Portfolio
6.11.5 4C Medical Technologies Recent Developments/Updates
6.12 Highlife
6.12.1 Highlife Corporation Information
6.12.2 Highlife Transcatheter Structural Heart Device Description and Business Overview
6.12.3 Highlife Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Highlife Product Portfolio
6.12.5 Highlife Recent Developments/Updates
6.13 Lepu Medical
6.13.1 Lepu Medical Corporation Information
6.13.2 Lepu Medical Transcatheter Structural Heart Device Description and Business Overview
6.13.3 Lepu Medical Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Lepu Medical Product Portfolio
6.13.5 Lepu Medical Recent Developments/Updates
6.14 Dinova Medtech
6.14.1 Dinova Medtech Corporation Information
6.14.2 Dinova Medtech Transcatheter Structural Heart Device Description and Business Overview
6.14.3 Dinova Medtech Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Dinova Medtech Product Portfolio
6.14.5 Dinova Medtech Recent Developments/Updates
6.15 NewMed Medical
6.15.1 NewMed Medical Corporation Information
6.15.2 NewMed Medical Transcatheter Structural Heart Device Description and Business Overview
6.15.3 NewMed Medical Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.15.4 NewMed Medical Product Portfolio
6.15.5 NewMed Medical Recent Developments/Updates
6.16 Venus Medtech
6.16.1 Venus Medtech Corporation Information
6.16.2 Venus Medtech Transcatheter Structural Heart Device Description and Business Overview
6.16.3 Venus Medtech Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Venus Medtech Product Portfolio
6.16.5 Venus Medtech Recent Developments/Updates
6.17 Hanyu Medical
6.17.1 Hanyu Medical Corporation Information
6.17.2 Hanyu Medical Transcatheter Structural Heart Device Description and Business Overview
6.17.3 Hanyu Medical Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Hanyu Medical Product Portfolio
6.17.5 Hanyu Medical Recent Developments/Updates
7 Transcatheter Structural Heart Device Manufacturing Cost Analysis
7.1 Transcatheter Structural Heart Device Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Transcatheter Structural Heart Device
7.4 Transcatheter Structural Heart Device Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Transcatheter Structural Heart Device Distributors List
8.3 Transcatheter Structural Heart Device Customers
9 Transcatheter Structural Heart Device Market Dynamics
9.1 Transcatheter Structural Heart Device Industry Trends
9.2 Transcatheter Structural Heart Device Growth Drivers
9.3 Transcatheter Structural Heart Device Market Challenges
9.4 Transcatheter Structural Heart Device Market Restraints
10 Global Market Forecast
10.1 Transcatheter Structural Heart Device Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Transcatheter Structural Heart Device by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Transcatheter Structural Heart Device by Type (2022-2027)
10.2 Transcatheter Structural Heart Device Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Transcatheter Structural Heart Device by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Transcatheter Structural Heart Device by Application (2022-2027)
10.3 Transcatheter Structural Heart Device Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Transcatheter Structural Heart Device by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Transcatheter Structural Heart Device by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer